Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Pediatr Pulmonol ; 59(5): 1482-1486, 2024 May.
Article in English | MEDLINE | ID: mdl-38390771

ABSTRACT

Diffuse cystic lung diseases (DCLDs) are a diverse group of lung disorders characterized by the presence of multiple air filled cysts within the lung tissue. These cysts are thin walled and surrounded by normal lung tissue. In adults, DCLD can be associated with various conditions such as lymphangioleiomyomatosis (LAM), Langerhans cell histiocytosis, cancers, and more. In children, DCLD is often linked to lung developmental abnormalities, with bronchopulmonary dysplasia being a common cause. Patients with pulmonary cysts are typically asymptomatic, but some may experience mild symptoms or pneumothorax. While DCLD in children is rarely due to malignancy, metastatic lung disease can be a cause. It is important for clinicians to be aware of the possibility of metastatic lung disease when encountering DCLD.


Subject(s)
Pulmonary Artery , Humans , Female , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/abnormalities , Pulmonary Artery/pathology , Adolescent , Lung Neoplasms/secondary , Lung Neoplasms/complications , Lung Neoplasms/pathology , Lung Neoplasms/diagnostic imaging , Aneurysm, False/diagnostic imaging , Cysts/diagnostic imaging , Cysts/complications , Lung Diseases/diagnostic imaging , Tomography, X-Ray Computed , Pregnancy
3.
Am J Hematol ; 95(7): 766-774, 2020 07.
Article in English | MEDLINE | ID: mdl-32243618

ABSTRACT

In the US, mortality in sickle cell disease (SCD) increases after age 18-20 years. Biomarkers of mortality risk can identify patients who need intensive follow-up and early or novel interventions. We prospectively enrolled 510 SCD patients aged 3-20 years into an observational study in 2006-2010 and followed 497 patients for a median of 88 months (range 1-105). We hypothesized that elevated pulmonary artery systolic pressure as reflected in tricuspid regurgitation velocity (TRV) would be associated with mortality. Estimated survival to 18 years was 99% and to 25 years, 94%. Causes of death were known in seven of 10 patients: stroke in four (hemorrhagic two, infarctive one, unspecified one), multiorgan failure one, parvovirus B19 infection one, sudden death one. Baseline TRV ≥2.7 m/second (>2 SD above the mean in age-matched and gender-matched non-SCD controls) was observed in 20.0% of patients who died vs 4.6% of those who survived (P = .012 by the log rank test for equality of survival). The baseline variable most strongly associated with an elevated TRV was a high hemolytic rate. Additional biomarkers associated with mortality were ferritin ≥2000 µg/L (observed in 60% of patients who died vs 7.8% of survivors, P < .001), forced expiratory volume in 1 minute to forced vital capacity ratio (FEV1/FVC) <0.80 (71.4% of patients who died vs 18.8% of survivors, P < .001), and neutrophil count ≥10x109 /L (30.0% of patients who died vs 7.9% of survivors, P = .018). In SCD children, adolescents and young adults, steady-state elevations of TRV, ferritin and neutrophils and a low FEV1/FVC ratio may be biomarkers associated with increased risk of death.


Subject(s)
Anemia, Sickle Cell , Tricuspid Valve Insufficiency , Adolescent , Adult , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/complications , Anemia, Sickle Cell/mortality , Anemia, Sickle Cell/physiopathology , Biomarkers/blood , Child , Child, Preschool , Disease-Free Survival , Female , Ferritins/blood , Follow-Up Studies , Humans , Leukocyte Count , Male , Neutrophils , Prospective Studies , Survival Rate , Tricuspid Valve Insufficiency/blood , Tricuspid Valve Insufficiency/etiology , Tricuspid Valve Insufficiency/mortality , Tricuspid Valve Insufficiency/physiopathology , United States/epidemiology , Young Adult
4.
Pediatr Pulmonol ; 55(3): 788-790, 2020 03.
Article in English | MEDLINE | ID: mdl-31986238

ABSTRACT

Endobronchial inflammatory myofibroblastic tumors (IMTs) rarely occur in children younger than 10 years of age and have intermediate malignant potential. A 7-year-old girl initially presented with pneumonia. After failing outpatient treatment, she re-presented in status asthmaticus. Computed tomography showed a left mainstem endobronchial mass which was resected bronchoscopically. Pathology was consistent with IMT. Surveillance bronchoscopy identified a recurrence. Despite a left upper lobectomy, recurrence led to further treatment with celecoxib and argon plasma coagulation. Follow-up bronchoscopy revealed complete resolution. She remains disease and symptom-free at her six-year follow-up.


Subject(s)
Granuloma, Plasma Cell/therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Argon Plasma Coagulation , Bronchoscopy , Celecoxib/therapeutic use , Child , Female , Granuloma, Plasma Cell/diagnosis , Humans , Recurrence , Tomography, X-Ray Computed
5.
Case Rep Pediatr ; 2019: 1471879, 2019.
Article in English | MEDLINE | ID: mdl-31093403

ABSTRACT

We discuss an adolescent female with cystic fibrosis, asthma, and scoliosis who had a rapid decline in her pulmonary function despite typical treatment for a cystic fibrosis exacerbation. Ultimately, she had a fixed airway obstruction likely due to her progressive scoliosis, which improved following surgical intervention.

6.
Clin Case Rep ; 5(6): 739-743, 2017 06.
Article in English | MEDLINE | ID: mdl-28588801

ABSTRACT

Patients with personal or family history of congenital hypothyroidism, and/or neurological findings that also have chronic respiratory symptoms may have a mutation in the NKX2.1 gene as the unifying cause of their disease. Brain-lung-thyroid disease is the ensuing condition, which although rare, needs to be part of the differential diagnosis.

7.
Med Educ Online ; 20: 28654, 2015.
Article in English | MEDLINE | ID: mdl-26547081

ABSTRACT

OBJECTIVE: Our objective was to evaluate the educational value of introducing pre-clinical medical students to pediatric patients and their families in a subspecialty clinic setting. METHODS: First- and second-year medical students at the University of Michigan seeking clinical experience outside of the classroom attended an outpatient pediatric pulmonary clinic. Evaluation of the experience consisted of pre- and post-clinic student surveys and post-clinic parent surveys with statements employing a four-point Likert scale as well as open-ended questions. RESULTS: Twenty-eight first-year students, 6 second-year students, and 33 parents participated in the study. Post-clinic statement scores significantly increased for statements addressing empathic attitudes, confidence communicating with children and families, comfort in the clinical environment, and social awareness. Scores did not change for statements addressing motivation, a sense of team membership, or confidence with career goals. Students achieved their goals of gaining experience interacting with patients, learning about pulmonary diseases, and observing clinic workflow. Parents felt that they contributed to student education and were not inconvenienced. CONCLUSIONS: Students identified several educational benefits of exposure to a single pediatric pulmonary clinic. Patients and families were not inconvenienced by the participation of a student. Additional studies are warranted to further investigate the value of this model of pre-clinical medical student exposure to subspecialty pediatrics.


Subject(s)
Ambulatory Care Facilities/organization & administration , Education, Medical, Undergraduate/organization & administration , Pediatrics/education , Pulmonary Medicine/economics , Students, Medical/psychology , Child , Clinical Competence , Communication , Empathy , Female , Humans , Male , Motivation , Self Concept , Young Adult
8.
J Pediatr Hematol Oncol ; 36(3): 185-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24309610

ABSTRACT

Obstructive and restrictive pulmonary changes develop in children with sickle cell disease, but reports conflict as to the type of change that predominates. We prospectively performed spirometry, plethysmography, and lung diffusing capacity in 146 children aged 7 to 20 years with hemoglobin SS or Sß(0)-thalassemia. Nineteen percent of the patients had obstructive physiology as defined according to guidelines of the American Thoracic Society. In addition, 9% had restrictive physiology and 11% had abnormal but not categorized physiology. Increasing age, patient-reported or family-reported history of asthma or wheezing, and higher lactate dehydrogenase concentration were independent predictors of obstruction as reflected in lower forced expiratory volume in the first second/forced vital capacity. In conclusion, abnormal pulmonary function, most often obstructive, is common in children with hemoglobin SS and Sß(0)-thalassemia. Full pulmonary function testing should be performed in children with hemoglobin SS or Sß(0)-thalassemia, especially with history of asthma or wheezing and accentuated elevations in hemolytic markers.


Subject(s)
Airway Obstruction/etiology , Anemia, Sickle Cell/complications , Asthma/etiology , Lung/physiopathology , Adolescent , Adult , Airway Obstruction/pathology , Anemia, Sickle Cell/pathology , Asthma/pathology , Child , Child, Preschool , Female , Follow-Up Studies , Forced Expiratory Volume , Humans , Male , Prognosis , Prospective Studies , Respiratory Function Tests , Respiratory Physiological Phenomena , Risk Factors , Young Adult
10.
Eur J Haematol ; 91(1): 62-8, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23560516

ABSTRACT

OBJECTIVES: We aimed to identify risk factors for acute pulmonary events in children and adolescents in the Pulmonary Hypertension and the Hypoxic Response in SCD (PUSH) study. METHODS: Patients with hemoglobin SS (n = 376) and other sickle cell genotypes (n = 127) aged 3-20 yrs were studied at four centers in a cross-sectional manner. A subgroup (n = 293) was followed for a median of 21 months (range 9-35). RESULTS: A patient-reported history of one or more acute pulmonary events, either acute chest syndrome (ACS) or pneumonia, was obtained in 195 hemoglobin SS patients (52%) and 51 patients with other genotypes (40%). By logistic regression, history of acute pulmonary events was independently associated with patient-reported history of asthma (P < 0.0001), older age (P = 0.001), >3 severe pain episodes in the preceding 12 months (P = 0.002), higher tricuspid regurgitation velocity (TRV) (P = 0.028), and higher white blood cell (WBC) count (P = 0.043) among hemoglobin SS patients. History of acute pulmonary events was associated with >3 severe pain episodes (P = 0.009) among patients with other genotypes. During follow-up, 43 patients (15%) had at least one new ACS episode including 11 without a baseline history of acute pulmonary events. History of acute pulmonary events (odds ratio 5.0; P < 0.0001) and younger age (odds ratio 0.9; P = 0.007) were independently associated with developing a new episode during follow-up. CONCLUSIONS: Asthma history, frequent pain, and higher values for TRV and WBC count were independently associated with history of acute pulmonary events in hemoglobin SS patients and frequent pain was associated in those with other genotypes. Measures to reduce pain episodes and control asthma may help to decrease the incidence of acute pulmonary events in SCD.


Subject(s)
Anemia, Sickle Cell/complications , Anemia, Sickle Cell/diagnosis , Hemoglobin, Sickle/genetics , Lung Diseases/complications , Lung Diseases/diagnosis , Adolescent , Adult , Child , Child, Preschool , Cross-Sectional Studies , Female , Genotype , Humans , Hypoxia , Male , Regression Analysis , Risk Factors , Time Factors , Vascular Diseases/complications , Vascular Diseases/diagnosis , Young Adult
11.
J Pediatr ; 160(2): 286-90, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21890147

ABSTRACT

OBJECTIVE: To identify factors associated with frequent severe vaso-occlusive pain crises in a contemporary pediatric cohort of patients with sickle cell anemia (SCA) enrolled in a prospective study of pulmonary hypertension and the hypoxic response in sickle cell disease. STUDY DESIGN: Clinical and laboratory characteristics of children with SCA who had ≥3 severe pain crises requiring health care in the preceding year were compared with those of subjects with <3 such episodes. RESULTS: Seventy-five children (20%) reported ≥3 severe pain episodes in the preceding year, and 232 (61%) had none. Frequent pain episodes were associated with older age (OR, 1.2; 95% CI, 1.1-1.3; P < .0001), α-thalassemia trait (OR 3.5; 1.6-6.7; P = .002), higher median hemoglobin (OR 1.7; 95% CI: 1.2-2.4; P < .003), and lower lactate dehydrogenase concentration (OR 1.82; 95% CI: 1.07-3.11; P = .027). Children with high pain frequency also had an increased iron burden (serum ferritin, 480 vs 198 µg/L; P = .006) and higher median tricuspid regurgitation jet velocity (2.41 vs 2.31 m/s; P = .001). Neither hydroxyurea use nor fetal hemoglobin levels were significantly different according to severe pain history. CONCLUSIONS: In our cohort of children with SCA, increasing age was associated with higher frequency of severe pain episodes as were α-thalassemia, iron overload, higher hemoglobin and lower lactate dehydrogenase concentration, and higher tricuspid regurgitation velocity.


Subject(s)
Anemia, Sickle Cell/complications , Pain/diagnosis , Pain/etiology , Vascular Diseases/diagnosis , Vascular Diseases/etiology , Acute Disease , Adolescent , Age Factors , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/physiopathology , Biomarkers , Child , Female , Hemoglobins/metabolism , Humans , In Vitro Techniques , Iron Overload/physiopathology , L-Lactate Dehydrogenase/blood , Male , Pain/blood , Pain/physiopathology , Prospective Studies , Risk Factors , Severity of Illness Index , Tricuspid Valve Insufficiency/etiology , Tricuspid Valve Insufficiency/physiopathology , Vascular Diseases/blood , Vascular Diseases/physiopathology , alpha-Thalassemia/physiopathology
12.
Am J Cardiol ; 104(5): 713-20, 2009 Sep 01.
Article in English | MEDLINE | ID: mdl-19699350

ABSTRACT

Pulmonary hypertension (PH) is associated with adverse outcomes in adults with sickle-cell disease (SCD), but its importance in children is less clear. The aim of this study was to define the incidence and causes of PH in pediatric patients with SCD. Children with SCD (n = 310) and matched controls (n = 54) were prospectively enrolled under basal conditions. Participants underwent echocardiography, pulse oximetry, 6-minute walk tests, and hematologic testing. Echocardiographic measures were compared between patients with SCD and control subjects before and after adjusting for hemoglobin. Correlations of echocardiographic and clinical parameters were determined. Tricuspid regurgitation velocity (TRV) was elevated compared to controls (2.28 vs 2.10 m/s, p <0.0001). Increased TRV was associated with left ventricular diastolic diameter, hemoglobin, and estimated left atrial pressure. TRV remained elevated when controlling for left ventricular diameter and left atrial pressure. Echocardiographically derived pulmonary resistance was not significantly different between patients with SCD and controls, although it was elevated in the SCD subgroup with elevated TRV. When controlling for hemoglobin, TRV was no longer statistically different, but pulmonary insufficiency velocity, septal wall thickness, and estimated pulmonary resistance were statistically higher. TRV, pulmonary insufficiency end-diastolic velocity, and markers of increased cardiac output were correlated with indicators of adverse functional status, including history of acute chest syndrome, stroke, transfusions, and 6-minute walk distance. In conclusion, children with SCD had mildly increased TRV that was correlated with increased cardiac output and left ventricular filling pressures. Hemoglobin-adjusted analysis also suggested a contribution of primary vascular changes.


Subject(s)
Anemia, Sickle Cell/complications , Hypertension, Pulmonary/diagnostic imaging , Cardiac Output , Child , Echocardiography, Doppler , Female , Humans , Hypertension, Pulmonary/epidemiology , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/physiopathology , Male , Prospective Studies , Tricuspid Valve/physiopathology , Vascular Resistance , Ventricular Function, Left
13.
Br J Haematol ; 147(3): 352-9, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19694721

ABSTRACT

Low steady state haemoglobin oxygen saturation in patients with sickle cell anaemia has been associated with the degree of anaemia and haemolysis. How much pulmonary dysfunction contributes to low saturation is not clear. In a prospective study of children and adolescents with sickle cell disease aged 3-20 years at steady state and matched controls, 52% of 391 patients versus 24% of 63 controls had steady state oxygen saturation <99% (P < 0.0001), 9% of patients versus no controls had saturation <95% (P = 0.008) and 8% of patients versus no controls had exercise-induced reduction in saturation > or =3%. Decreasing haemoglobin concentration (P < or = 0.001) and increasing haemolysis (P < or = 0.003) but not pulmonary function tests were independent predictors of both lower steady-state saturation and exercise-induced reduction in saturation. Neither history of stroke nor history of acute chest syndrome was significantly associated with lower steady-state oxygen saturation or exercise-induced reduction in saturation. Tricuspid regurgitation velocity was higher in patients with lower steady state haemoglobin oxygen saturation (P = 0.003) and with greater decline in oxygen saturation during the six-minute walk (P = 0.022). In conclusion, lower haemoglobin oxygen saturation is independently associated with increasing degrees of anaemia and haemolysis but not pulmonary function abnormalities among children and adolescents with sickle cell disease.


Subject(s)
Anemia, Sickle Cell/blood , Exercise/physiology , Hemoglobins/metabolism , Oxygen/blood , Adolescent , Anemia, Sickle Cell/physiopathology , Child , Child, Preschool , Exercise Test/methods , Hemolysis , Humans , Logistic Models , Prospective Studies , Respiratory Function Tests/methods , Respiratory Physiological Phenomena , Young Adult
14.
Rev. peru. pediatr ; 62(1): 25-28, ene.-mar. 2009.
Article in Spanish | LILACS, LIPECS | ID: lil-559007

ABSTRACT

La fibrosis quística es una enfermedad multisistémica con afección predominante de vías respiratorias. La causa predominante de morbiûmortalidad es el compromiso respiratorio. Uno de los fenómenos fisiopatológicos primarios en fibrosis quística es la depleción de la capa líquida de la superficie de las vías respiratorias. La enfermedad pulmonar se debe a la incapacidad del epitelio de las vías respiratorias para mantener hidratada su superficie. La causa fundamental del daño pulmonar es la obstrucción de bronquios y bronquiolos por secreciones espesas, infección endobronquial y enfermedad obstructiva progresiva. El mecanismo de acción de la solución salina hipertónica sería la restauración de la capa de líquido superficial del epitelio respiratorio por medio de la introducción de un gradiente osmótico en la superficie de las vías respiratorias. La presente revisión enfoca el uso de la solución salina hipertónica, y nos da la oportunidad de revisar un aspecto fundamental de la fisiopatología de la enfermedad y entender la importancia relativa de una de las terapias menos costosas en el manejo crónico de enfermedad pulmonar en fibrosis quística.


Cystic fibrosis is a multisystemic disease that predominantly affects the airways. The main cause of morbidity and mortality is the respiratory compromise. The depletion of the airway surface liquid is felt to be one of the main pathophysiologic events. The pulmonary disease is caused by the inability of the airways to keep their surface hydrated with airway plugging, infection and progressive obstructive lung disease. The mechanism of action of hypertonic saline is felt to be the restoration of the airway surface liquid with the introduction of an osmotic gradient on the surface of the airways. This review focuses on the use of hypertonic saline because it gives us the opportunity to discuss a fundamental pathophysiologic aspect of the disease and understand the relative importance of one of the less expensive therapies for the pulmonary disease in cystic fibrosis.


Subject(s)
Humans , Cystic Fibrosis , Saline Solution, Hypertonic/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...